Institutional members access full text with Ovid®

Share this article on:

Circulating Angiogenic Factors in Preeclampsia

Levine, Richard J MD, MPH*; Karumanchi, S Ananth MD

Clinical Obstetrics and Gynecology: June 2005 - Volume 48 - Issue 2 - p 372-386
doi: 10.1097/01.grf.0000160313.82606.d7
New Developments in Preeclampsia

*Division of Epidemiology, Statistics and Prevention Research, National Institute of Child Health and Human Development, Department of Health and Human Services, Bethesda, Maryland; and the †Departments of Medicine, Obstetrics and Gynecology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts

Correspondence: Richard J. Levine, MD, NIH/NICHD, Building 6100, Rm. 7B03, Bethesda, MD 20892. E-mail:

This work was supported through intramural funding by the National Institute of Child Health and Human Development to RJL and by NIH grants (DK 064255 and DK065997) and the American Society of Nephrology Carl W. Gottschalk Research Scholar Award to SAK.

Dr. Karumanchi is listed as coinventor on a patent filed by the Beth Israel Deaconess Medical Center for the use of angiogenic proteins for the diagnosis and treatment of preeclampsia.

© 2005 Lippincott Williams & Wilkins, Inc.